Kymera Therapeutics (KYMR) PT Raised to $59 at Jefferies

October 31, 2024 4:11 PM

Jefferies analyst Kelly Shi raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $59.00 (from $44.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found